AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 272 filers reported holding AVANOS MED INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,062,477 | +29.5% | 103,538 | +29.5% | 0.01% | +25.0% |
| Q1 2024 | $1,592,442 | +27.4% | 79,982 | +43.6% | 0.00% | +33.3% |
| Q4 2023 | $1,249,575 | -47.0% | 55,710 | -52.2% | 0.00% | -50.0% |
| Q3 2023 | $2,358,198 | +633.6% | 116,627 | +827.3% | 0.01% | +500.0% |
| Q2 2023 | $321,468 | -42.4% | 12,577 | -50.9% | 0.00% | -50.0% |
| Q3 2022 | $558,000 | -84.1% | 25,617 | -80.1% | 0.00% | -83.3% |
| Q2 2022 | $3,518,000 | -55.6% | 128,678 | -45.6% | 0.01% | -47.8% |
| Q1 2022 | $7,918,000 | +8.7% | 236,352 | +12.5% | 0.02% | +43.8% |
| Q4 2021 | $7,284,000 | +10.8% | 210,081 | -0.3% | 0.02% | +6.7% |
| Q3 2021 | $6,573,000 | +498.1% | 210,682 | +597.1% | 0.02% | +650.0% |
| Q2 2021 | $1,099,000 | +413.6% | 30,223 | +314.9% | 0.00% | +100.0% |
| Q2 2020 | $214,000 | -91.2% | 7,284 | -79.5% | 0.00% | -85.7% |
| Q3 2018 | $2,429,000 | – | 35,455 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,441,913 | $88,812,000 | 4.12% |
| RGM Capital, LLC | 2,157,612 | $78,472,000 | 3.63% |
| Millrace Asset Group, Inc. | 32,253 | $1,173,000 | 0.61% |
| HEARTLAND ADVISORS INC | 240,724 | $8,755,000 | 0.51% |
| Champlain Investment Partners, LLC | 2,607,033 | $94,818,000 | 0.45% |
| Campbell & CO Investment Adviser LLC | 27,200 | $989,000 | 0.41% |
| S.A. Mason LLC | 5,565 | $202,000 | 0.14% |
| XTX Topco Ltd | 8,240 | $300,000 | 0.10% |
| AIGEN INVESTMENT MANAGEMENT, LP | 15,186 | $552,000 | 0.10% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 16,875 | $614,000 | 0.09% |